Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance

Overview of attention for article published in Molecular Cancer, June 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 58 Dimensions

Readers on

mendeley: 83 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 31 followers.

#stopaging Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and ov... http://t.co/fo40LnotH1 #cancer #cancercure

Reply Repost Favourite